U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07276958) titled 'A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)' on Dec. 01.
Brief Summary: The purpose of this study is to investigate the safety and tolerability of LY4298445 in healthy participants and in participants with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA). Participation in the study will last up to approximately 52 weeks.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Intervention:
DRUG: LY4298445
Administered SC
DRUG: LY4298445
Administered IV
Re...